Back to news

Daxor Expands Midwest Footprint with Launch of ezBVA Lab Program at Premier Kansas Academic Medical Center

Globe Newswire•17/11/2026•08:00 ET
0

Key Highlights

  • ➤Kansas academic medical center launches Daxor’s ezBVA Lab program
  • ➤ezBVA Lab provides 24-hour blood volume diagnostics with zero upfront capex
  • ➤Turnkey model expands Daxor’s Midwest footprint and supports scalable test volumes
  • ➤Daxor says established reimbursement can accelerate hospital adoption and recurring utilization

Expert Statements

Annette Plishka, Senior Vice President of Commercialization at Daxor

“Launching our BVA program at a major academic medical center in Kansas demonstrates continued commercial momentum in the Midwest and underscores the scalability of our ezBVA Lab model”

Annette Plishka, Senior Vice President of Commercialization at Daxor

“By removing upfront capital barriers and leveraging established reimbursement, we enable hospitals to adopt precision volume measurement rapidly, driving recurring test utilization while reducing readmissions and total cost of care.”

Turnkey ezBVA Lab Model Removes Capital Barriers and Leverages Established Reimbursement to Drive Rapid Clinical Adoption.

Oak Ridge, TN, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced the commercial launch of a new Blood Volume Analysis (BVA(®)) program at a leading academic medical center in Kansas, expanding the company’s Midwest footprint and accelerating adoption of its centralized diagnostic service.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in